Evidence on the efficacy of systemic therapy for unresectable NAM is scarce, but immune checkpoint inhibitors and BRAF/MEK inhibitors have superseded conventional cytotoxic chemotherapy. Here, BRAF is linked to Bailey-Bloch congenital myopathy.